Latest Commercialisation News

Tamboran Resources’ Shenandoah South 2H sidetrack well has achieved a record 90-day average gas flow rate in the Beetaloo Basin, maintaining stable production and advancing the company’s multi-well drilling campaign.

Green360 Technologies has successfully raised A$4 million through a share placement to fund the commercialisation and scaling of its innovative low-carbon cement technology, supported by institutional investors and strengthened leadership.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

FBR Limited has raised A$2 million through a share placement and purchase plan, complementing a $20 million subscription facility, to fund new robotic products, strategic partnerships, and debt repayment.

Neometals has agreed to sell its 50% stake in the lithium-ion battery recycling joint venture Primobius to SMS Group for €5 million upfront plus future royalties, marking a strategic pivot away from capital-intensive projects.

Papyrus Australia appoints Daniel Schmidt as CEO to lead its transition from R&D to commercial operations, alongside a strategic restructure to support growth.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Silex Systems has raised $130 million through an institutional placement to advance its SILEX uranium enrichment technology in the US, bolstering its financial position through FY2028.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.

Southern Cross Gold Consolidated has announced a major metallurgical advancement at its Sunday Creek project, delivering a high-grade, low-arsenic antimony-gold concentrate alongside excellent gold recovery. This development enhances the project's economic potential amid shifting global supply dynamics for critical metals.

FBR Limited has locked in a A$20 million share subscription facility with GEM Global Yield LLC, providing flexible capital to advance its innovative robotics platforms and commercialisation efforts.